BioGenCell presented the preliminary results of its clinical trial at the Global Investor Forum Maastricht, an opportunity for Israeli startups in RegMed and MedTech. The Global Investor Forum exposes promising Biomed Start-Ups and joins the powerful global BIOMED network of the world’s leading investors, entrepreneurs, corporates and key physicians. The focus was on Regenerative Medicine and Medical Devices.

Share this Article
Share on facebook
Share on linkedin
Share on email